Biotech-related exchange-traded funds were among the day's top performers, helped by an 18% jump in shares of
Earlier, the company said it will be acquired by
in an arrangement worth more than $15 billion.
SPDR S&P Biotech
ETF was gaining $1.02, or 2%, to $52.96. The
HealthShares Emerging Cancer
was higher by 47 cents, or 1.8%, to $26.94. The
First Trust Amex Biotechnology Index
tacked on 38 cents, or 1.5%, to $26.01. The
iShares Nasdaq Biotechnology
ETF was recently up $1.01, or 1.2%, to $82.47.
Bundled securities tracking the energy sector were also among the winners of the day thanks to a gain in oil prices. The front-month June crude contract was recently adding $1.15 to $65.26 a barrel.
iPath Goldman Sachs Crude Oil Index
was rising 75 cents, or 2.1%, to $37.30. The
United States Oil
ETF gained 92 cents, or 1.8%, to $50.97. The
PowerShares DB Energy
ETF was climbing 44 cents, or 1.6%, to $27.87.
On the other hand, housing-related ETFs were the worst performers of the session. Among individual housing names,
was sinking 2.9%,
slumped 2.2%, and
was down 1.8%.
iShares Dow Jones U.S. Home Construction
ETF was recently down 69 cents, or 1.9%, at $36.37. The
ETF was losing 60 cents, or 1.7%, to $34.49.